Stocktoria
Viatris Inc VTRS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1973-02-01
Viatris Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 35.1% | 38.2% | 41.7% | 40.0% | 31.2% |
| Operating margin | -18.6% | 0.1% | 5.0% | 9.9% | -0.2% |
| FCF margin | 13.5% | 13.4% | 16.4% | 15.9% | 14.3% |
| Debt / equity | 0.85× | 0.75× | 0.79× | 0.85× | 0.96× |
| Current ratio | 1.38 | 1.65 | 1.67 | 1.58 | 1.10 |
| Revenue growth | -3.0% | -4.5% | -5.1% | -9.1% | 49.7% |
Source: SEC EDGAR filings · CIK 0001792044 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.